The in vitro parameters of cell-mediated immunity were studied in 20 children with an established diagnosis of Juvenile rheumatoid arthritis (JRA) (age range 4-15 years) and 23 age-and sex-matched healthy children. (No attempt was made to correlate the observed changes with clinical course or treatment.) We are not certain, at this time, of clinical relevancy or the generalizability of the findings. The normal level of T-lymphocytes (CD3 + ) and normal proportions of CD4 + and CD8 + lymphocytes were seen in children with JRA. The in vitro response of lymphocytes to T-cell mitogen phytohemagglutinin (PHA) also was normal. The suppressor activity of JRA monocytes was essentially the same as controls. In contrast, monocytes from patients with JRA showed the following: decreased expression of receptors for Fc part of IgG immunoglobulin (FcR), diminished nitro blue tetrazolium (NBT) reduction activity, and depressed expression of Ia.7 major histocompatibility complex (MHC) class II determinants. This indicates that certain monocyte functions in selected patients with a variety of manifestations of JRA are depressed.
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JUVENILE RHEUMATOID ARTHRITIS
(JRA) is a systemic connective tissue disease of unknown etiology and clinical heterogeneity.I-3 Multi- ple factors may be important in pathogenesis: infectious agents, stress, immunological abnormalities.I,2 2 The immunogenetic backgroud of JRA is supported by known association of this disease with certain HLA class II antigens.4-6 The immunologic factors that may be important for pathogenesis include: the presence of autoantibodies (antilymphocytic, anti-DNA, rheumatoid factor), immune complexes, hyperactivity of B cells (hypergammaglobulinemia, increased spontaneous secretion of immunoglobulins, elevated level of B lymphocytes, etc. ), and, finally, abnormal immunoregulation.2,3,6-8 Systemic lupus erythematosis (SLE) may be considered as an adult counterpart of JRA. Several immunologic abnormalities are observed in SLE.9-11 The monocyte-macrophage dysfunction: depressed clearance of antibody-coated erythrocytes, depressed expression of receptor for Fc part of immunoglobulin (FcR) and lowered expression of HLA-DR determinants have been described,',', 12 though its relevance to the pathogenesis of disease is unclear.
Recent study on bone degradation activity of monocytes in JRA suggests that mononuclear phagocytes are capable of contributing to the pathogenetical process.&dquo; Against this background and presump-tive analogy of JRA to SLE, these studies were undertaken to establish whether monocyte aberrant activity may occur in children with JRA. This paper shows that certain functions of monocytes are altered in some JRA patients.
Materials and Methods

Patient Population
Twenty children with an established diagnosis of JRA were included. Nine patients were boys (age range 4-12 years) and 11 were girls (age range [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] years). Fifteen children showed symptoms of polyarthritis (six boys and nine girls) and five children presented as oligoarthritis (three boys and two girls). All patients were receiving nonsteroidal antiinflammatory medication at the time of immunologic examination. Twenty-three healthy children (12 boys and 11 I girls) aged 6-13 years were used as control group.
No attempt was made to relate the clinical course of the patients to the laboratory findings.
Monoclonal Antibodies
Ortho-mune OKT3 (anti-CD3, IgG2a), OKT4 (anti-CD4, IgG2b) and OKT8 (anti-CD8, IgG2) monoclonal antibodies (mAbs) were purchased from Ortho Diagnostic Systems (Raritan, NJ) and used according to standard procedure. Mouse mAb HAK75 (anti-DR, IgG2b) obtained from Professor T. Tada, University of Tokyo, Japan) and 14-4-4S (anti-Ia.7, IgG2a) (gift of Dr. D. Sachs, NIH, Bethesda, Md) were used. HAK75 was originally produced against mouse determinant encoded by I-Ak and found to crossreact with human HLA-DR antigens. 14 The other mAB 14-4-4S detects determinant encoded by I-Ek subregion and also react with alpha chain of HLA-DR.I5,I6 These reagents have been previously described in detail. 11, 15 The ascitic fluid was used at final dilution of 1:I28. Anti-Leul (IgG2a) and anti-Leu6 (IgG2b) mAbs were purchased from Becton-Dickinson (Mountain View, CA).
Isolation of Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells (PBMC) were obtained from EDTA-venous blood (5-10 ml) by Ficoll/Isopaque centrifugation and resuspended at 10~/ml in RPMI-1640 medium (Gibco, Irvine, Scotland) containing antibiotics, 2 mM L-glutamine (Gibco), 4 mM Hepes (Gibco) and 10 percent fetal calf serum (FCS, Gibco).
Determination of T Cells and Their Subsets
The number of T cells expressing CD3, CD4, and CD8 determinants was assessed in an indirect fluorescence. PBMC were incubated with OKT3, OKT4, and OKT8 mAb for 30 min on ice, washed 3 times, and then incubated for 20 min in the cold with FITC-F(ab')2 antimouse immunoglobulin antiserum (F2883 Sigma, St. Louis, MO). The number of positive cells was determined in wet smears using an epifluorescent microscope (Opton). The number of cells in PBMC suspension forming rosettes with human &dquo;0&dquo; Rh+(D) erythrocytes coated with IgG anti-D antibody (EAhu) was determined with simultaneous counting of monocytes identified by euchrysine (acridine orange, BDH, Poole, England) fluorescent microscopy. 21, 22 Spontaneous Nitro Blue Tetrazolium Reduction Test
(NBT)
This test was performed as previously described. 23 The extent of NBT reduction by granulocyte-free PBMC was determined spectrophotometrically and expressed as O.D.580. PBMC containing more than 2 percent granulocytes were excluded.
Determination of HLA Class 11 Determinants on
Monocytes
Isolated AC ( 105 cells/0.1 ml) were incubated with an equal amount of 1:128 diluted ascites of HAK75 or 14-4-4S mAb for 30 min on ice. As a control staining anti-Leul (IgG2a) and anti-Leu6 (IgG2b) mAbs were used. After washing, FITC-conjugated F(ab')2 fragment of anti-mouse IgG diluted 1:30 was added and cells were incubated for 30 min in the cold. Wet smears were read using an Opton epifluorescent microscope. Two hundred cells were counted and the results were expressed as the percentage of positive cells.
Statistics A generalized non-parametric Wilcoxon-Mann-Whitney two-tailed test was used to assess the differences between groups.24 The difference was regarded as significant when p < 0.05.
Results
The Phenotype and Function of T Cells
The number of T lymphocytes (CD3') and their CD4' and CD8' subpopulations were determined in 14 children with JRA using monoclonal antibodies directed against CD3, CD4, and CD8 determinants. Figure 1 shows that the total level of T cells, i. e., reacting with mAb OKT3 was almost identical to that found in a control group. Also the number of CD4' and CD8' cells was the same as in a control group. This suggested that no major changes in the distribution of T cells and their subpopulations were seen in JRA. This was corroborated by functional tests, as the in vitro response of lymphocytes to the T-cell mitogen, PHA, was similar to control values.
Monocyte Suppressor Activity in nitro
Monocytes isolated from patients or control individuals were cocultured with normal PBMC stimulated with PHA to assess their immunoregulatory ac- tivity. Figure 2 shows that the addition of 2 X 104 JRA monocytes to PHA-stimulated cultures did not cause any appreciable suppression while control monocytes showed some inhibition. It was concluded that monocytes with increased immunoregulatory activity were not found in our population of children with JRA.
The Expression of Fc Receptor on Monocytes of
Children with JRA The number of cells reacting with antibody-coated erythrocytes (EA) in PBMC (EA+ cells) with simultaneous staining of cells with euchrysine was determined. The number of monocytes forming rosettes with EA (FcR' cells) also was calculated. Figure 3 shows that the number of EA+ cells was decreased in children with JRA but the differences were nonsignificant. However, the number of FcR' monocytes was significantly depressed (p < 0.05). This indicated that monocytes of children with JRA are characterized by diminished expression of FcR.
The NBT Reduction Activity of Monocytes
The ability of granulocyte-free PBMC to reduce NBT reflects the metabolic state of monocytes. 21,23 This test was applied to PBMC of children with JRA. It was found that spontaneous reduction of NBT by monocytes was significantly impaired in these children (Fig. 4 ). This may suggest that this function of monocyte in this disease is depressed.
The Expression of MHC Class II Determinants on Monocytes of Children with JRA
The expression of HLA-DR and Ia.7 determinants on isolated monocytes was assessed by their reactivity with HAK75 and 14-4-4S mAb. Figure 5 shows that the number of monocytes expressing HLA-DR determinants in JRA and control group was comparable. In contrast, monocytes of JRA patients had significantly depressed expression of Ia.7 determinant. It was concluded that monocytes of JRA children had impaired expression of certain MHC class II determinants.
Discussion
Clinical observations suggest that JRA is a heterogenous disease.I-3 Although immunologic factors are implicated in JRA, its etiology and pathomechanism remain unknown. These immunologic factors include the occurrence of autoantibodies and immune complexes in some patients.6,7,25 Abnormalities of immunoregulation are implicated but not proven.~ 3 The present paper showed that cellular immunity is normal in our population of patients as judged from normal level of T lymphocytes (as determined by OKT3 mAb) and normal ratio of CD4/CD8 lymphocytes. It is in keeping with other recent observations.~ This conclusion is further supported by the finding that the in vitro response of lymphocytes to T-cell mitogen, PHA, also was normal. The latter contradicts that previous reports indicating that proliferative responses of lymphocytes to mitogens and antigens are diminished. 8, 26 In contrast to normal cellular immunity, humoral responses appear to be abnormal. Increased immunoglobulin level, particularly IgG, elevated spontaneous secretion of immunoglobulins by B cells, and increased B-lymphocyte level was reported.2'4 Furthermore, depressed PWM-induced immunoglobulin production by B cells in vitro was observed, which improved upon monocyte removal and was taken as an evidence for the presence of suppressor monocytes.1I Our studies using cocultures of isolated JRA monocytes with normal PBMC stimulated with PHA did not revealed the presence of suppressor monocytes (Fig. 2 ). This apparent contradiction may be due to the different assay system used or that perhaps different monocyte subsets may be responsible for suppression of immunoglobulin secretion and lymphoproliferation.28 However, using the same assay system, we have demonstrated suppressor activity of monocytes obtained from cancer patients. 17'20 It also is noteworthy that in patients with systemic lupus erythematoses (SLE), suppressor monocytes cannot be demonstrated. 12 Finally, in our experience, suppressor activity of monocytes either activated in vitro or obtained from patients with cancer is related to increased expression of FcR.I7. 23, 27 In JRA, opposite is true (vide infra). The most striking abnormalities of monocytes seen in our children with JRA were: decreased expression of FcR, diminished NBT reduction activity, and depressed expression of Ia.7 class II determinants. This indicates that certain functions of monocytes may be depressed in such patients. The decreased expression of FcR is analogous to SLE, in which abnormal function of macrophage FcR was found, using the clearance of IgG anti-Rh(D)-sensitized erythrocytes. 10.1 1 Although JRA is not regarded as a classical immune complex disease, this observation may indicate that impaired function of monocytes leading to a defective handling of immune complexes may have important immunopathogenetical implications. It also FIG. 5 . The number of HLA-DR~ D and Ia.7~ EI monocytes isolated from patients with JRA and control group reacting with HAK75 and I4-4-4S mAbs, respectively. is interesting that spontaneous NBT reduction activity of monocytes, which may be taken as an index of metabolic activity, 23 also is diminished, further supporting the view that certain functions of monocytes are depressed in at least some of these patients.
The present paper also shows that expression of some MHC class II determinants on monocytes is depressed in JRA. The number of monocytes expressing Ia.7, but not HLA-DR, determinants was found to be significantly lowered. It is interesting as Ia.7 determinant is only expressed on a subpopulation of peripheral blood monocytes that is important for accessory function of these cells.&dquo; This implies that monocyte abnormalities seen in JRA may be confined to a particular subset of mononuclear phagocytes. The expression of this determinant on monocytes seems to be increased in cancer patients.28
On the other hand, a lack of altered expression of monocyte HLA-DR is puzzling as it is known to be depressed in SLE patients.&dquo; Further studies using other mAbs with different MHC anti-class II specificity are needed to elucidate the relevance of the present findings. Both clinical and immunologic data indicate that JRA may be an autoimmune disease. 2,5,6,8 This is also supported by its known association with HLA-DR5 antigen.26 It is conceivable that alteration in the HLA-class II antigens expression on monocytes may have important implications for the immunoregulatory activity of these cells as well as for the development and progression of JRA. Further studies are required to establish whether the diminished number of Ia.7+ monocytes is due to a production of antimonocytic autoantibodies as seen in patients with SLE.12
